Standards of care for JIA—the basic foundation for quality
- 1 July 2010
- journal article
- editorial
- Published by Springer Nature in Nature Reviews Rheumatology
- Vol. 6 (7) , 389-390
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- The effect of infliximab plus methotrexate on the modulation of inflammatory disease markers in juvenile idiopathic arthritis: analyses from a randomized, placebo-controlled trialPediatric Rheumatology, 2010
- BSPAR Standards of Care for children and young people with juvenile idiopathic arthritisRheumatology, 2010
- Clinical Trial Design in Neonatal Pharmacology: Effect of Center Differences, With Lessons From the Pediatric Oncology Cooperative Research ExperienceClinical Pharmacology & Therapeutics, 2009
- Premature atherosclerosis in pediatric systemic lupus erythematosus: Risk factors for increased carotid intima‐media thickness in the atherosclerosis prevention in pediatric lupus erythematosus cohortArthritis & Rheumatism, 2009
- Adalimumab with or without Methotrexate in Juvenile Rheumatoid ArthritisNew England Journal of Medicine, 2008
- Abatacept in children with juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled withdrawal trialThe Lancet, 2008